The Immunogenicity and Safety of Shingrix Vaccine in Patients With Moderate to Severe Ulcerative Colitis on Tofacitinib
Phase of Trial: Phase IV
Latest Information Update: 06 Aug 2019
Price : $35 *
At a glance
- Drugs GSK 1437173A (Primary)
- Indications Herpes zoster
- Focus Pharmacodynamics
- 31 Jul 2019 Status changed from not yet recruiting to recruiting.
- 22 May 2019 Planned initiation date changed from 1 May 2019 to 1 Jul 2019.
- 01 May 2019 Planned initiation date changed from 1 Apr 2019 to 1 May 2019.